Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-21-006914
Filing Date
2021-03-23
Accepted
2021-03-23 16:48:23
Documents
1
Period of Report
2021-03-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3891
  Complete submission text file 0001437749-21-006914.txt   5293
Mailing Address C/O PHASE III MEDICAL, INC. 330 SOUTH SERVICE ROAD, SUITE 120 MELVILLE NY 11747
Business Address
VACZY CATHERINE M (Reporting) CIK: 0001177176 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38244 | Film No.: 21765355

Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Issuer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations